<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yonsei Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Yonsei Med. J</journal-id>
      <journal-id journal-id-type="publisher-id">YMJ</journal-id>
      <journal-title-group>
        <journal-title>Yonsei Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0513-5796</issn>
      <issn pub-type="epub">1976-2437</issn>
      <publisher>
        <publisher-name>Yonsei University College of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26069113</article-id>
      <article-id pub-id-type="pmc">4479859</article-id>
      <article-id pub-id-type="doi">10.3349/ymj.2015.56.4.928</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
          <subj-group subj-group-type="heading">
            <subject>Infectious Disease</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>In Vivo</italic> Selection of Pan-Drug Resistant <italic>Acinetobacter baumannii</italic> during Antibiotic Treatment</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Yoonjung</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bae</surname>
            <given-names>Il Kwon</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Jeong</surname>
            <given-names>Seok Hoon</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yong</surname>
            <given-names>Dongeun</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Kyungwon</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Dental Hygiene, Silla University, Busan, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>
Corresponding author: Dr. Seok Hoon Jeong, Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Korea. Tel: 82-2-2228-2448, Fax: 82-2-313-0956, <email>kscpjsh@yuhs.ac</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <volume>56</volume>
      <issue>4</issue>
      <fpage>928</fpage>
      <lpage>934</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>7</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>03</day>
          <month>9</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Copyright: Yonsei University College of Medicine 2015</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>Colistin resistance in <italic>Acinetobacter baumannii</italic> (<italic>A. baumannii</italic>) is mediated by a complete loss of lipopolysaccharide production via mutations in <italic>lpxA</italic>, <italic>lpxC,</italic> and <italic>lpxD</italic> gene or lipid A modifications via mutations in the <italic>pmrA</italic> and <italic>pmrB</italic> genes. However, the exact mechanism of therapy-induced colistin resistance in <italic>A. baumannii</italic> is not well understood.</p>
        </sec>
        <sec>
          <title>Materials and Methods</title>
          <p>We investigated the genotypic and phenotypic changes that underlie pan-drug resistance mechanisms by determining differences between the alterations in extensively drug-resistant (XDR) <italic>A. baumannii</italic> (AB001 and AB002) isolates and a pan-drug resistant (PDR) counterpart (AB003) recovered from one patient before and after antibiotic treatment, respectively.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>All three clinical isolates shared an identical sequence type (ST138), belonging to the global epidemic clone, clonal complex 92, and all produced OXA-23 carbapenemase. The PDR AB003 showed two genetic differences, acquisition of <italic>armA</italic> gene and an amino acid substitution (Glu229Asp) in <italic>pmrB</italic> gene, relative to XDR isolates. No mutations were detected in the <italic>pmrA</italic>, <italic>pmrC</italic>, <italic>lpxA</italic>, <italic>lpxC</italic>, or <italic>lpxD</italic> genes in all three isolates. In matrix-assisted laser desorption ionization-time of flight analysis, the three isolates commonly showed two major peaks at 1728 m/z and 1912 m/z, but peaks at 2034 m/z, 2157 m/z, 2261 m/z, and 2384 m/z were detected only in the PDR <italic>A. baumannii</italic> AB003 isolate.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Our results show that changes in lipid A structure via a mutation in the <italic>pmrB</italic> gene and acquisition of <italic>armA</italic> gene might confer resistance to colistin and aminoglycosides to XDR <italic>A. baumannii</italic> strains, resulting in appearance of a PDR <italic>A. baumannii</italic> strain of ST138.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd><italic>pmrB</italic> gene</kwd>
        <kwd><italic>armA</italic> gene</kwd>
        <kwd>colistin</kwd>
        <kwd>lipid A</kwd>
        <kwd>
          <italic>Acinetobacter baumannii</italic>
        </kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source country="KR">Korea Centers for Disease Control &amp; Prevention</funding-source>
          <award-id>2014E4700200#</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>The extensive use of antimicrobial agents and the propensity of pathogenic bacteria that accumulate antimicrobial resistance have led to a considerable increase in pathogenic bacteria acquiring resistance to multiple categories of antimicrobial agents. As this problem continues to grow, the definition of terms such as multidrug resistant (MDR), extensively drug-resistant (XDR), and pan-drug resistant (PDR) strains were standardized in order to more specifically define those microorganisms. MDR strains are defined as non-susceptible to at least one agent in three or more antimicrobial categories, XDR strains are defined as non-susceptible to at least one agent in all but two or fewer antimicrobial categories, and PDR strains are defined as non-susceptible to all agents in all antimicrobial categories.<xref rid="B1" ref-type="bibr">1</xref></p>
      <p><italic>Acinetobacter baumannii (A. baumannii)</italic> is associated with infections including bacteremia, pneumonia, meningitis, and urinary tract infections especially in patients hospitalized in intensive care units (ICUs).<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref> The prevalence of XDR <italic>A. baumannii</italic> isolates with carbapenem resistance has persistently increased, and most of XDR <italic>A. baumannii</italic> isolates in Asia belong to the globally-distributed clone, clonal complex 92.<xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr">5</xref><xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">7</xref> After the reintroduction of colistin in clinical practice to treat infections caused by XDR <italic>A. baumannii</italic> due to the lack of applicable antibiotics, the emergence of PDR <italic>A. baumannii</italic> strains with colistin resistance has repeatedly been reported in many parts of the world.<xref rid="B8" ref-type="bibr">8</xref><xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref><xref rid="B11" ref-type="bibr">11</xref></p>
      <p>According to a few <italic>in vitro</italic> studies regarding colistin resistance mechanisms in <italic>A. baumannii</italic>, colistin resistance is mediated by a complete loss of lipopolysaccharide (LPS) production via mutations in LPS producing genes (<italic>lpxA</italic>, <italic>lpxC,</italic> and <italic>lpxD</italic>) or by mutations in the <italic>pmrA</italic> and <italic>pmrB</italic> genes that encode a two-component signal transduction system.<xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">13</xref> However, the exact mechanism of therapy-induced colistin resistance in <italic>A. baumannii</italic> is not well understood.</p>
      <p>Here, we studied colistin resistance mechanisms by evaluating the genetic alterations between two colistin-susceptible XDR <italic>A. baumannii</italic> clinical isolates and a colistin-resistant counterpart isolated from one patient before and after colistin therapy, respectively. Furthermore, we investigated the genetic determinants of antimicrobial resistance to various antibiotics and the molecular epidemiology of the clinical isolates.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>MATERIALS AND METHODS</title>
      <sec>
        <title>Patient characteristics and bacterial strains</title>
        <p>A 72-year-old man with a history of hypertension, atrial fibrillation, and diabetes mellitus was admitted to the emergency department of a tertiary-care hospital in Seoul, Korea, on August 29th, 2011 due to abdominal pain. Abdominal computed tomography revealed an impending thoracoabdominal aortic aneurysm, and a graft replacement of the abdominal aorta was performed. After emergency surgery, he was admitted to the ICU and was mechanically ventilated from day one. He was treated with ciprofloxacin (400 mg/day) and piperacillin+tazobactam (6.75 g/day). An XDR <italic>A. baumannii</italic> isolate (AB001) was first recovered from a respiratory tract specimen on day five, and it was then serially recovered from respiratory tract specimens. And an XDR <italic>A. baumannii</italic> isolate (AB002) was recovered from a urinary specimen on day six. Intravenous administration of colistimethate sodium (150 mg/day) was started on day six. After five days of colistin therapy, a colistin-resistant <italic>A. baumannii</italic> isolate (AB003) was recovered from a blood specimen, which prompted the physicians to change antibiotics to tigecycline. However, urinary tract infection, acute renal failure, atelectasis at both lungs, and sepsis were not controlled. On day 17, the patient was transferred to a local hospital near the patient's home for continuation of treatment. In this study, we included the two colistin-susceptible XDR <italic>A. baumannii</italic> isolates (AB001 and AB002), which were recovered from the respiratory tract and urinary specimens, respectively, and their colistin-resistant counterpart (AB003). The isolates were identified as <italic>A. baumannii</italic> using the Vitek GNI system (bioM&#xE9;rieux, Marcy l'Etoile, France) and sequence analysis of the RNA polymerase &#x3B2;-subunit (<italic>rpoB</italic>) gene.<xref rid="B14" ref-type="bibr">14</xref>
<italic>A. baumannii</italic> ATCC 19606 was used as the reference strain.</p>
      </sec>
      <sec>
        <title>Antimicrobial susceptibility testing</title>
        <p>Antimicrobial susceptibilities were determined using antibiotic-containing disks (Becton Dickinson, Sparks, MD, USA) on Mueller-Hinton agar (Difco Laboratories, Detroit, MI, USA). The minimum inhibitory concentrations (MICs) of meropenem and imipenem were determined using the agar dilution method, and the MIC of colistin was determined by the E-test (bioM&#xE9;rieux) according to the Clinical and Laboratory Standards Institute guidelines.<xref rid="B15" ref-type="bibr">15</xref></p>
      </sec>
      <sec>
        <title>Multi-locus sequence typing (MLST)</title>
        <p>PCR and sequencing experiments were performed on seven housekeeping genes encoding citrate synthase (<italic>gltA</italic>), DNA gyrase subunit B (<italic>gyrB</italic>), glucose dehydrogenase B (<italic>gdhB</italic>), homologous recombination factor (<italic>recA</italic>), 60-kDa chaperonin (<italic>cpn60</italic>), glucose-6-phosphate isomerase (<italic>gpi</italic>), and RNA polymerase sigma factor (<italic>rpoD</italic>), as described previously.<xref rid="B6" ref-type="bibr">6</xref><xref rid="B16" ref-type="bibr">16</xref> Nucleotide sequences of both strands were determined. Allelic profiles of the seven housekeeping genes and STs of the strains were analyzed using the <italic>Acinetobacter</italic> MLST database (<ext-link ext-link-type="uri" xlink:href="http://www.pasteur.fr/recherche/genopole/PF8/mlst/">http://www.pasteur.fr/recherche/genopole/PF8/mlst/</ext-link>).</p>
      </sec>
      <sec>
        <title>Pulsed-field gel electrophoresis (PFGE)</title>
        <p>Pulsed-field gel electrophoresis (PFGE) was performed with <italic>Sma</italic>I-digested genomic DNA extracted from the three isolates using a CHEF-DRII device (Bio-Rad, Hercules, CA, USA). The conditions of PFGE were 6 V/cm for 20 h with pulse times of 3-10 seconds at a temperature of 11&#x2103;. <italic>Sma</italic>I-digested band patterns were analyzed using Molecular Analyst Fingerprinting Software Ver. 3.2 (Bio-Rad). The PFGE patterns were interpreted using the criteria of Tenover, et al.<xref rid="B17" ref-type="bibr">17</xref></p>
      </sec>
      <sec>
        <title>Characterization of antimicrobial resistance determinants</title>
        <p>PCR and sequence analysis of antimicrobial resistance determinants including <italic>bla</italic><sub>OXA51</sub>-like, <italic>bla</italic><sub>OXA-23</sub>, <italic>bla</italic><sub>AmpC</sub>, <italic>gyrA</italic>, <italic>parC</italic>, and <italic>armA</italic> genes were performed according to methods described in previous studies.<xref rid="B18" ref-type="bibr">18</xref><xref rid="B19" ref-type="bibr">19</xref><xref rid="B20" ref-type="bibr">20</xref><xref rid="B21" ref-type="bibr">21</xref> The presence of IS <italic>Aba1</italic> upstream of the <italic>bla</italic><sub>OXA51</sub>-like, <italic>bla</italic><sub>OXA-23</sub>, and <italic>bla</italic><sub>AmpC</sub> genes was also evaluated.<xref rid="B22" ref-type="bibr">22</xref> LPS-producing genes (<italic>lpxA</italic>, <italic>lpxC</italic>, and <italic>lpxD</italic>) and <italic>pmrA</italic> and <italic>pmrB</italic> genes encoding a two-component signal transduction system were sought by PCR and sequencing.<xref rid="B13" ref-type="bibr">13</xref><xref rid="B23" ref-type="bibr">23</xref> Briefly, genomic DNA was extracted using a QIAamp DNA extraction kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. After PCR, amplicons were purified using a QIAquick Gel Extraction Kit (Qiagen) and sequenced using an ABI 3500dx system (Applied Biosystems, Foster City, CA, USA). Sequences for all antimicrobial resistance determinant loci in <italic>A. baumannii</italic> isolates were compared using the GenBank database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>) with reference sequences of <italic>A. baumannii</italic> ATCC 17978 (GenBank accession number CP000 521).</p>
      </sec>
      <sec>
        <title>Analysis of lipid A structure</title>
        <p>LPS and lipid A were extracted from whole bacterial cells using Tri-Reagent extraction and mild acid hydrolysis methods, and were then subjected to negative-ion matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometer (Bruker Daltonik GmbH, Leipzig, Germany) analysis in the negative reflective mode.<xref rid="B24" ref-type="bibr">24</xref></p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>RESULTS</title>
      <sec>
        <title>Antimicrobial susceptibilities and antimicrobial resistance determinants</title>
        <p>The antimicrobial resistance determinants of the two colistin-susceptible XDR <italic>A. baumannii</italic> isolates (AB001 and AB002) and a PDR <italic>A. baumannii</italic> isolate (AB003) were evaluated. All three isolates showed resistance to ciprofloxacin, and they contained the <italic>gyrA</italic> gene with an amino acid substitution (Ser83Leu). While isolates AB001 and AB002 showed susceptibility to amikacin and gentamicin, the AB003 isolate showed resistance to these aminoglycosides and harbored the <italic>armA</italic> gene. All three isolates showed resistance to ceftazidime and cefepime, and they carried and the IS<italic>Aba1-bla</italic><sub>AmpC</sub> structure. MICs of imipenem and meropenem for all three isolates were greater than 32 mg/L, and they carried the <italic>bla</italic><sub>OXA-23</sub> gene with an insertion sequence IS<italic>Aba1</italic> upstream of the gene. The MIC of colistin for both AB001 and AB002 isolates was 0.25 mg/L, while that for AB003 isolate was 16 mg/L (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="table" rid="T2">2</xref>).</p>
      </sec>
      <sec>
        <title>Strain type</title>
        <p>All three isolates were identified as an identical ST, ST 138 (1-3-3-2-2-50-3), and they showed identical <italic>Sma</italic>I-macrorestriction patterns by PFGE (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p>
      </sec>
      <sec>
        <title>Molecular analysis of the colistin-susceptible/resistant isogenic clinical isolates</title>
        <p>The sequences of the <italic>pmrB</italic> gene in the two colistin-susceptible AB001 and AB002 isolates were identical to those of the reference <italic>A. baumannii</italic> ATCC 17978, whereas the PDR <italic>A. baumannii</italic> AB003 isolate harbored a novel mutation (encoding a Glu229Asp change) in the <italic>pmrB</italic> gene (<xref ref-type="table" rid="T2">Table 2</xref>). No mutations were detected in the <italic>pmrA</italic>, <italic>pmrC</italic>, <italic>lpxA</italic>, <italic>lpxC</italic>, and <italic>lpxD</italic> genes in all three isolates.</p>
      </sec>
      <sec>
        <title>Analysis of lipid A structure</title>
        <p>The two colistin-susceptible AB001 and AB002 isolates and the PDR <italic>A. baumannii</italic> AB003 isolate all showed two major peaks at 1729 m/z and 1911 m/z in negative-ion MALDI-TOF mass spectra. These two major peaks most likely correspond to <italic>bis</italic>-phosphorylated hexa- and hepta-acylated lipid A, respectively. Spectra for the lipid A structure from the PDR <italic>A. baumannii</italic> AB003 isolate were distinct from those of AB001 and AB002, as it showed additional peaks at 2034 m/z, 2157 m/z, 2261 m/z, and 2384 m/z (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The extensive use of antimicrobial agents has led to a considerable increase in MDR, XDR, and PDR pathogenic bacteria. Colistin has resurfaced as effective last resort for treatment of infections caused by XDR <italic>A. baumannii</italic>. Many studies evaluated the resistance mechanisms against polymyxins, and analysed effectiveness of colistin monotherapy as well as the combination therapy to reduce the colistin resistance and toxicity of colistin.<xref rid="B8" ref-type="bibr">8</xref><xref rid="B10" ref-type="bibr">10</xref><xref rid="B25" ref-type="bibr">25</xref> Despite the efforts, colistin therapy-related colistin-resistant <italic>A. baumannii</italic> strains have been isolated.<xref rid="B10" ref-type="bibr">10</xref><xref rid="B26" ref-type="bibr">26</xref><xref rid="B27" ref-type="bibr">27</xref> A complete loss of LPS production via mutations in LPS-producing genes (<italic>lpxA</italic>, <italic>lpxC</italic>, and <italic>lpxD</italic>) and the modification of lipid A components via mutations in the <italic>pmrAB</italic> gene have been evaluated in various studies with <italic>in vitro</italic> manipulated colisitn-resistant <italic>A. baumannii.</italic><xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">13</xref> Between two colistin-resistance mechanisms, only mutations in the <italic>pmrA</italic> (Met12Ile; Met12Lys) or <italic>pmrB</italic> gene (Gln270Pro; Gln277Lys) were found in clinical isolates from patient who has been treated with colistin. In our study, AB003 harbored Glu229Asp mutation in the <italic>pmrB</italic> gene, while the isolate carried wild-type LPS-producing genes (<italic>lpxA</italic>, <italic>lpxC</italic>, and <italic>lpxD</italic>). The mutant <italic>pmrAB</italic> genes are involved in LPS modification by adding 4-amino-4-deoxy-L-arabinose (Ara4N) and/or phosphoethanolamine (pEtN) to lipid A.<xref rid="B23" ref-type="bibr">23</xref><xref rid="B28" ref-type="bibr">28</xref><xref rid="B29" ref-type="bibr">29</xref> In MALDI-TOF analysis, we observed the expected spectra ion peaks of 1728 m/z and 1912 m/z in all three isolates, AB001, AB002, and AB003. However, the peaks of 2034 m/z, 2157 m/z, 2261 m/z, and 2384 m/z were detected only in the AB003 strain, which contained the <italic>pmrB</italic> mutation. Possibly, these peaks were generated by the addition of one or two pEtN (123 m/z) residues to <italic>bis</italic>-phosphorylated hepta- and octa-acylated lipid A molecules. These modifications should affect the electrostatic interaction of certain cationic antimicrobial-peptide resistance determinants with the bacterial cell surface, and act as one of the colistin-resistant mechanisms.<xref rid="B30" ref-type="bibr">30</xref><xref rid="B31" ref-type="bibr">31</xref></p>
      <p>In our study, the AB003 acquired a mutation in the <italic>pmrB</italic> gene after five days of colistin therapy. It should be a short period of time to obtain a resistance, but colistin resistant <italic>A. baumannii</italic> were collected from patients who received colistin therapy for 7-19 days.<xref rid="B26" ref-type="bibr">26</xref><xref rid="B32" ref-type="bibr">32</xref></p>
      <p>The AB003 strain also harbored the <italic>armA</italic> gene and showed resistance to amikacin (&lt;9 mm of disk diffusion test). After admission, the patient did not received aminoglycoside agents, such as tobramycin and amikacin. Therefore, it is highly likely that the <italic>armA</italic> is located on plasmids was incidentally transferred from another <italic>A. baumannii</italic> clone.<xref rid="B18" ref-type="bibr">18</xref><xref rid="B33" ref-type="bibr">33</xref></p>
      <p>In our study, all three isolates showed identical <italic>Sma</italic>I-macrorestriction patterns by PFGE and identified as an identical ST, ST 138 (1-3-3-2-2-50-3), indicating that they are a clone. All three isolates shared the <italic>gyrA</italic> gene with a same mutation, and they carried identical resistance genes IS <italic>Aba1-bla</italic><sub>AmpC</sub> and IS<italic>Aba1-bla</italic><sub>OXA-23</sub>. However, AB003 carried only the <italic>pmrB</italic> gene with a mutation of Glu229Asp and the <italic>armA</italic> gene. Therefore, AB003 might acquire resistance to colistin and aminoglycosides by <italic>in vivo</italic> selection during colistin treatment from the XDR parental strains (AB001 and AB002).</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGEMENTS</title>
      <p>This work was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (2014E4700200#).</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p>The authors have no financial conflicts of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Magiorakos</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carey</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Carmeli</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Falagas</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Giske</surname>
              <given-names>CG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>268</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="pmid">21793988</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>CT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nosocomial outbreak of infection with multidrug-resistant Acinetobacter baumannii in a medical center in Taiwan</article-title>
          <source>Infect Control Hosp Epidemiol</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>34</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="pmid">19049437</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maragakis</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Perl</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options</article-title>
          <source>Clin Infect Dis</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>1254</fpage>
          <lpage>1263</lpage>
          <pub-id pub-id-type="pmid">18444865</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Koo</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Spread and genetic characterization of ST137 and ST138 multidrug-resistant Acinetobacter baumannii isolated from a tertiary hospital in Korea</article-title>
          <source>Ann Clin Lab Sci</source>
          <year>2013</year>
          <volume>43</volume>
          <fpage>145</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="pmid">23694788</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Endo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yano</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hirakata</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Arai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kanamori</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2012</year>
          <volume>67</volume>
          <fpage>1623</fpage>
          <lpage>1626</lpage>
          <pub-id pub-id-type="pmid">22447879</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>IK</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2011</year>
          <volume>66</volume>
          <fpage>66</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">21051374</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Qiao</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zong</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study</article-title>
          <source>BMC Microbiol</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>234</fpage>
          <pub-id pub-id-type="pmid">24144168</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chai</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2012</year>
          <volume>67</volume>
          <fpage>1607</fpage>
          <lpage>1615</lpage>
          <pub-id pub-id-type="pmid">22441575</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yong</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens</article-title>
          <source>Yonsei Med J</source>
          <year>2011</year>
          <volume>52</volume>
          <fpage>879</fpage>
          <lpage>891</lpage>
          <pub-id pub-id-type="pmid">22028150</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Hara</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Ambe</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Casella</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Townsend</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Pelletier</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>RK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2013</year>
          <volume>57</volume>
          <fpage>2103</fpage>
          <lpage>2108</lpage>
          <pub-id pub-id-type="pmid">23422916</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valencia</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Arroyo</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Conde</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aldana</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez-Cuenca</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital</article-title>
          <source>Infect Control Hosp Epidemiol</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>257</fpage>
          <lpage>263</lpage>
          <pub-id pub-id-type="pmid">19199531</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adams</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Nickel</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Bajaksouzian</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lavender</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Murthy</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>3628</fpage>
          <lpage>3634</lpage>
          <pub-id pub-id-type="pmid">19528270</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moffatt</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hale</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Vinogradov</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Seemann</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2010</year>
          <volume>54</volume>
          <fpage>4971</fpage>
          <lpage>4977</lpage>
          <pub-id pub-id-type="pmid">20855724</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>La Scola</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gundi</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Khamis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Raoult</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species</article-title>
          <source>J Clin Microbiol</source>
          <year>2006</year>
          <volume>44</volume>
          <fpage>827</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="pmid">16517861</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="book">
          <collab>Clinical and Laboratory Standards Institute</collab>
          <source>Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement, M100-S22</source>
          <publisher-loc>Wayne (PA)</publisher-loc>
          <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>
          <year>2012</year>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bartual</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Seifert</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hippler</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Luzon</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Wisplinghoff</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez-Valera</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii</article-title>
          <source>J Clin Microbiol</source>
          <year>2005</year>
          <volume>43</volume>
          <fpage>4382</fpage>
          <lpage>4390</lpage>
          <pub-id pub-id-type="pmid">16145081</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tenover</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Arbeit</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Goering</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Mickelsen</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Persing</surname>
              <given-names>DH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing</article-title>
          <source>J Clin Microbiol</source>
          <year>1995</year>
          <volume>33</volume>
          <fpage>2233</fpage>
          <lpage>2239</lpage>
          <pub-id pub-id-type="pmid">7494007</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals</article-title>
          <source>Diagn Microbiol Infect Dis</source>
          <year>2009</year>
          <volume>64</volume>
          <fpage>185</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="pmid">19361944</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vila</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ruiz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Go&#xF1;i</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jimenez de Anta</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii</article-title>
          <source>J Antimicrob Chemother</source>
          <year>1997</year>
          <volume>39</volume>
          <fpage>757</fpage>
          <lpage>762</lpage>
          <pub-id pub-id-type="pmid">9222045</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vila</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ruiz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Go&#xF1;i</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Marcos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jimenez de Anta</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>1995</year>
          <volume>39</volume>
          <fpage>1201</fpage>
          <lpage>1203</lpage>
          <pub-id pub-id-type="pmid">7625818</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Woodford</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ellington</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Coelho</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Turton</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp</article-title>
          <source>Int J Antimicrob Agents</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>351</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="pmid">16564159</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Hsia</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Sheng</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>MH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2010</year>
          <volume>54</volume>
          <fpage>2078</fpage>
          <lpage>2084</lpage>
          <pub-id pub-id-type="pmid">20194701</pub-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beceiro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Llobet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Aranda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bengoechea</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Doumith</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hornsey</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2011</year>
          <volume>55</volume>
          <fpage>3370</fpage>
          <lpage>3379</lpage>
          <pub-id pub-id-type="pmid">21576434</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yi</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Hackett</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria</article-title>
          <source>Analyst</source>
          <year>2000</year>
          <volume>125</volume>
          <fpage>651</fpage>
          <lpage>656</lpage>
          <pub-id pub-id-type="pmid">10892021</pub-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petrosillo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ioannidou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Falagas</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>816</fpage>
          <lpage>827</lpage>
          <pub-id pub-id-type="pmid">18844682</pub-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>L&#xF3;pez-Rojas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jim&#xE9;nez-Mej&#xED;as</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Lepe</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Pach&#xF3;n</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain</article-title>
          <source>J Infect Dis</source>
          <year>2011</year>
          <volume>204</volume>
          <fpage>1147</fpage>
          <lpage>1148</lpage>
          <pub-id pub-id-type="pmid">21881133</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>L&#xF3;pez-Rojas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McConnell</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Jim&#xE9;nez-Mej&#xED;as</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Dom&#xED;nguez-Herrera</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez-Cuenca</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pach&#xF3;n</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2013</year>
          <volume>57</volume>
          <fpage>4587</fpage>
          <lpage>4589</lpage>
          <pub-id pub-id-type="pmid">23836165</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arroyo</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Herrera</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hankins</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Trent</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Hancock</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2011</year>
          <volume>55</volume>
          <fpage>3743</fpage>
          <lpage>3751</lpage>
          <pub-id pub-id-type="pmid">21646482</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gunn</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more</article-title>
          <source>Trends Microbiol</source>
          <year>2008</year>
          <volume>16</volume>
          <fpage>284</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="pmid">18467098</pub-id>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gunn</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Krueger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hackett</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance</article-title>
          <source>Mol Microbiol</source>
          <year>1998</year>
          <volume>27</volume>
          <fpage>1171</fpage>
          <lpage>1182</lpage>
          <pub-id pub-id-type="pmid">9570402</pub-id>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cotter</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Raetz</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>43111</fpage>
          <lpage>43121</lpage>
          <pub-id pub-id-type="pmid">11535603</pub-id>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>IK</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Yong</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment</article-title>
          <source>Diagn Microbiol Infect Dis</source>
          <year>2014</year>
          <volume>79</volume>
          <fpage>362</fpage>
          <lpage>366</lpage>
          <pub-id pub-id-type="pmid">24809861</pub-id>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gordon</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Wareham</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance</article-title>
          <source>Int J Antimicrob Agents</source>
          <year>2010</year>
          <volume>35</volume>
          <fpage>219</fpage>
          <lpage>226</lpage>
          <pub-id pub-id-type="pmid">20047818</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title><italic>Sma</italic>I-macrorestiction patterns of two colistin-susceptible isolates (AB001 and AB002) and a colistin-resistant isolate (AB003). All three isolates showed 100% of similarity.</title>
      </caption>
      <graphic xlink:href="ymj-56-928-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <title>Mass spectrometry of lipid A extracted from the colistin-susceptible isolates (A) AB001 and (B) AB002 and their colistin-resistant counterpart (C) AB003 with Glu229Asp in <italic>pmrB</italic> gene. In MALDI-TOF analysis, AB001, AB002, and AB003 isolates all showed two major peaks at 1728 m/z and 1912 m/z, but peaks at 2034 m/z, 2157 m/z, 2261 m/z, and 2384 m/z were detected only in the PDR <italic>A. baumannii</italic> AB003 isolate. MALDI-TOF, matrix-assisted laser desorption ionization-time of flight; PDR, pan-drug resistant.</title>
      </caption>
      <graphic xlink:href="ymj-56-928-g002"/>
    </fig>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <title>Characteristics of <italic>A. baumannii</italic> Clinical Isolates Included in This Study</title>
      </caption>
      <alternatives>
        <graphic xlink:href="ymj-56-928-i001"/>
        <table frame="hsides" rules="rows">
          <thead>
            <tr>
              <th valign="middle" align="left" rowspan="2" colspan="1">Isolate<sup>*</sup></th>
              <th valign="middle" align="center" rowspan="1" colspan="6">Antimicrobial susceptibilities (inhibition zone diameter, mm)</th>
              <th valign="middle" align="center" rowspan="1" colspan="3">MIC (mg/mL)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">MLST</th>
            </tr>
            <tr>
              <th valign="middle" align="center" rowspan="1" colspan="1">CAZ</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">CTX</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">FEP</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">AN</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">GM</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">CIP</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">CL</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">MEM</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">IPM</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">ST</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">AB001</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (10)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">S (24)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">S (18)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="right" rowspan="1" colspan="1">0.25</td>
              <td valign="top" align="center" rowspan="1" colspan="1">256</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64</td>
              <td valign="top" align="center" rowspan="1" colspan="1">138</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">AB002</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (10)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">S (23)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">S (17)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="right" rowspan="1" colspan="1">0.25</td>
              <td valign="top" align="center" rowspan="1" colspan="1">256</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64</td>
              <td valign="top" align="center" rowspan="1" colspan="1">138</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">AB003</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (11)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">R (9)</td>
              <td valign="top" align="right" rowspan="1" colspan="1">16</td>
              <td valign="top" align="center" rowspan="1" colspan="1">256</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64</td>
              <td valign="top" align="center" rowspan="1" colspan="1">138</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p>AN, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; CL, colistin; CTX, cefotaxime; FEP, cefepime; GM, gentamicin; IPM, imipenem; MEM, meropenem; MLST, multi-locus sequence typing; R, resistance; S, susceptible; ST, sequence type.</p>
          <p><sup>*</sup>AB001 and AB002 are colistin-susceptible isolates and AB003 is the colistin-resistant counterpart.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T2" orientation="portrait" position="float">
      <label>Table 2</label>
      <caption>
        <title>Antibiotic Resistance Genes of <italic>Acinetobacter baumannii</italic> Clinical Isolates</title>
      </caption>
      <alternatives>
        <graphic xlink:href="ymj-56-928-i002"/>
        <table frame="hsides" rules="rows">
          <thead>
            <tr>
              <th valign="middle" align="left" rowspan="2" colspan="1">Strain<sup>&#x2020;</sup></th>
              <th valign="middle" align="center" rowspan="1" colspan="4">Detected antimicrobial resistance determinants</th>
              <th valign="middle" align="center" rowspan="1" colspan="5">Detected mutations</th>
            </tr>
            <tr>
              <th valign="middle" align="center" rowspan="1" colspan="1"><italic>bla</italic><sub>OXA-51</sub>-like<sup>*</sup></th>
              <th valign="middle" align="center" rowspan="1" colspan="1">IS<italic>Aba1</italic>-<italic>bla</italic><sub>OXA-23</sub></th>
              <th valign="middle" align="center" rowspan="1" colspan="1">IS<italic>Aba1</italic>-<italic>bla</italic><sub>AmpC</sub></th>
              <th valign="middle" align="center" rowspan="1" colspan="1">
                <italic>armA</italic>
              </th>
              <th valign="middle" align="center" rowspan="1" colspan="1">
                <italic>gyrA</italic>
              </th>
              <th valign="middle" align="center" rowspan="1" colspan="1">
                <italic>parC</italic>
              </th>
              <th valign="middle" align="center" rowspan="1" colspan="1">
                <italic>pmrB</italic>
              </th>
              <th valign="middle" align="center" rowspan="1" colspan="1"><italic>pmrA</italic> and <italic>C</italic></th>
              <th valign="middle" align="center" rowspan="1" colspan="1"><italic>lpxA</italic>, <italic>C</italic>, and <italic>D</italic></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="middle" align="left" rowspan="1" colspan="1">AB001</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">ND</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">Ser83Leu</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">Ser80Leu</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">WT</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">WT</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">WT</td>
            </tr>
            <tr>
              <td valign="middle" align="left" rowspan="1" colspan="1">AB002</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">ND</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">Ser83Leu</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">Ser80Leu</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">WT</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">WT</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">WT</td>
            </tr>
            <tr>
              <td valign="middle" align="left" rowspan="1" colspan="1">AB003</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">+</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">Ser83Leu</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">Ser80Leu</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">Glu229Asp (A
&#x2192;
T substitution at nt687)</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">WT</td>
              <td valign="middle" align="center" rowspan="1" colspan="1">WT</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p>ND, not detected; WT, wild type.</p>
          <p><sup>*</sup>IS<italic>Aba1</italic> upstream of <italic>bla</italic><sub>OXA-51</sub>-like was not detected in all isolates.</p>
          <p><sup>&#x2020;</sup>Genes detected by PCR and sequencing.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
